InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting

Name: Aglaia Oncology Funds
Address: Prof. Bronkhorstlaan 10, building 92, Bilthoven, 3723 MB
Telephone: +31 (0)30 - 229 60 90

October 31, 2019

InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting.

Please click here to read the InteRNA Poster#138 showing the data.

Contact

Businesspark Berg en Bosch

Prof. Bronkhorstlaan 10, building 92

3723 MB Bilthoven

T +31 (0)30 - 229 60 90

F +31 (0)30 - 229 60 99

Aglaia Management B.V. is registered with the Trade Register of the Chamber of Commerce and Industry under number 54970857.